The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 06, 2025
Filed:
Dec. 17, 2018
Applicant:
Intervet Inc., Rahway, NJ (US);
Inventors:
Mark A. Mogler, Ames, IA (US);
Pravina Kitikoon, Overland Park, KS (US);
Supraja Puttamreddy, Ames, IA (US);
Erin Strait, Spring Hill, KS (US);
Ruud Philip Antoon Maria Segers, Boxmeer, NL;
Basav Nagaraj, Wageningen, NL;
Assignee:
Intervet Inc., Rahway, JE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2005.12); A61K 49/00 (2005.12); A61P 31/16 (2005.12); C12N 9/24 (2005.12); A61K 39/00 (2005.12);
U.S. Cl.
CPC ...
A61K 39/145 (2012.12); A61K 49/00 (2012.12); A61P 31/16 (2017.12); C12N 9/2402 (2012.12); A61K 2039/5256 (2012.12); A61K 2039/53 (2012.12); A61K 2039/552 (2012.12); A61K 2039/55566 (2012.12); A61K 2039/70 (2012.12);
Abstract
The present invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The present invention also provides vaccine against influenza A virus comprising such vectors and/or nucleic acid constructs. The present invention further provides methods of making and using the vaccines alone, or in combination with other protective agents.